Nos publications scientifiques

Département d’Onco-Ophtalmologie Niçois
DOON > La recherche sur les cancers oculaires > Nos publications scientifiques

C’est à la qualité des publications scientifiques que l’on évalue le travail des chercheurs. Ces publications dans des revues internationales comme Nature, Nature Genetics, the Lancet, PLoS One, PLoS Medicine, Gut, the New England Journal of Medicine… sont le reflet de l’excellence de la production. La bibliométrie, incluant une évaluation quantitative des facteurs d’impact dans les revues prestigieuses, reflète l’intérêt de la communauté scientifique pour les découvertes qui sont ainsi reprises et citées.

La bibliométrie évalue l’activité de la recherche en appliquant des méthodes statistiques aux publications scientifiques (bibliographie des articles, signatures des articles, mots-clés et auteurs,…). Elle permet de mesurer la production scientifique et la notoriété d’un chercheur, d’un laboratoire, d’un établissement, d’un pays, d’un domaine de recherche…

Nos publications

2020

  • Bellini L, Strub T, Habel N, Pandiani C, Marchetti S, Martel A, Baillif S, Bailly-Maitre B, Gual P, Ballotti R, Bertolotto C. Endoplasmic reticulum stress mediates resistance to BCL-2 inhibitor in uveal melanoma cells. Cell Death Discov. 2020;6:22.
  • de Parisot A, Jamilloux Y, Kodjikian L, Errera M-H, Sedira N, Heron E, Pérard L, Cornut P-L, Schneider C, Rivière S, Ollé P, Pugnet G, Cathébras P, Manoli P, Bodaghi B, Saadoun D, Baillif S, Tieulie N, André M, Chiambaretta F, Bonin N, Bielefeld P, Bron A, Mouriaux F, Bienvenu B, Amamra N, Guerre P, Decullier E, Sève P, ULISSE group. Evaluating the cost-consequence of a standardized strategy for the etiological diagnosis of uveitis (ULISSE study). PLoS One. 2020;15(2):e0228918.
  • Strub T, Ballotti R, Bertolotto C. The “ART” of Epigenetics in Melanoma: From histone “Alterations, to Resistance and Therapies.” Theranostics. 2020;10(4):1777–97.
  • El Chehab H, Gatinel D, Baudouin C, Muraine M, Hoffart L, Rozot P, Mehanna C, Bonnet C, Nordmann J-P, Santiago P-Y, Burillon C, Baillif S, Pisella PJ, Weber M, Robinet-Perrin A, Deidier D, Hay A, Villain M, Baïkoff G, Gauthier AS, Mathis T, Dot C. Complications of cosmetic iris implants: French series of 87 eyes. J Cataract Refract Surg. 2020 Jan;46(1):34–9.
  • Heeke S, Benzaquen J, Hofman V, Ilié M, Allegra M, Long-Mira E, Lassalle S, Tanga V, Salacroup C, Bonnetaud C, Fayada J, Gazoppi L, Ribeyre L, Castelnau O, Garnier G, Cattet F, Nanni I, de Fraipont F, Cohen C, Berthet J-P, Leroy S, Poudenx M, Marquette CH, Denis MG, Barlesi F, Hofman P. Critical Assessment in Routine Clinical Practice of Liquid Biopsy for EGFR Status Testing in Non-Small-Cell Lung Cancer: A Single-Laboratory Experience (LPCE, Nice, France). Clin Lung Cancer. 2020 Jan;21(1):56-65.e8.
  • Mathis T, Caujolle J-P, Thariat J. Choroidal Metastasis From Melanoma Treated by Cyberknife Irradiation. JAMA Ophthalmol. 2020 Jan 1;138(1):e190388.
  • Marcault C, Venton G, Gastaud L, Mannone L, Rey J, D’Incan E, Saillard C, Charbonnier A, Raynaud S, Vey N, Cluzeau T. Alternative Effective and Safe Induction Regimens for Newly Diagnosed Acute Myeloid Leukemia in Patients With Cardiac Contraindication to Anthracyclines. Clin Lymphoma Myeloma Leuk. 2020 Feb;20(2):e76–81.
  • Couret C, Poinas A, Volteau C, Riche V-P, Le Lez M-L, Errera M-H, Creuzot-Garcher C, Baillif S, Kodjikian L, Ivan C, Le Jumeau de Kergaradec LM, Chiffoleau A, Jobert A, Jaulin J, Biron L, Hervouet E, Weber M. Comparison of two techniques used in routine care for the treatment of inflammatory macular oedema, subconjunctival triamcinolone injection and intravitreal dexamethasone implant: medical and economic importance of this randomized controlled trial. Trials. 2020 Feb 10;21(1):159.
  • Mathis T, Espensen CA, Caujolle J-P, Herault J, Fog LS, Maschi C, Kodjikian L, Baillif S, Kiilgaard JF, Thariat J. Ultra-widefield fundus photography for radiation therapy planning of ocular tumours. Acta Ophthalmol. 2020 Mar;98(2):e191–6.
  • Lassalle S, Hofman V, Heeke S, Benzaquen J, Long E, Poudenx M, Lantéri E, Boutros J, Tanga V, Zahaf K, Lalvée S, Lespinet V, Bordone O, Félix J-M, Bonnetaud C, Marquette C, Ilie M, Hofman P. Targeted Assessment of the EGFR Status as Reflex Testing in Treatment-Naive Non-Squamous Cell Lung Carcinoma Patients: A Single Laboratory Experience (LPCE, Nice, France). Cancers (Basel). 2020 Apr 13;12(4).
  • Chiabo J, Nahon-Esteve S, Alketbi M, Lassalle S, Tieulie N, Martel A. Orbital non-HIV immune reconstitution inflammatory syndrome after cytapheresis. Eur J Ophthalmol. 2020 Apr 21;1120672120919339.
  • Calleja A, Yun S, Moreilhon C, Karsenti JM, Gastaud L, Mannone L, Komrokji R, Al Ali N, Dadone-Montaudie B, Robert G, Auberger P, Raynaud S, Sallman DA, Cluzeau T. Clonal selection in therapy-related myelodysplastic syndromes and acute myeloid leukemia under azacitidine treatment. Eur J Haematol. 2020 May;104(5):488–98.
  • Gardin C, Pautas C, Fournier E, Itzykson R, Lemasle E, Bourhis J-H, Adès L, Marolleau J-P, Malfuson J-V, Gastaud L, Raffoux E, Lambert J, Braun T, Thomas X, Chantepie S, Cluzeau T, de Botton S, Berthon C, Boissel N, Duployez N, Terré C, Peffault de Latour R, Michallet M, Celli-Lebras K, Preudhomme C, Dombret H. Added prognostic value of secondary AML-like gene mutations in ELN intermediate-risk older AML: ALFA-1200 study results. Blood Adv. 2020 May 12;4(9):1942–9.
  • Weber M, Dominguez M, Coscas F, Faure C, Baillif S, Kodjikian L, Cohen S-Y. Impact of intravitreal aflibercept dosing regimens in treatment-naïve patients with neovascular age-related macular degeneration: 2-year results of RAINBOW. BMC Ophthalmol. 2020 May 25;20(1):206.
  • Arndt C, Audrun F, Bodaghi B, Caujolle J-P, Cassoux N, Defoort S, Delyfer M-N, Denis P, Doan S, Fenolland J-R, Giraud J-M, Kodjikian L, Labetoulle M, Lasudry J, Leveziel N, Rousseau A, Saadoun D, Speeg-Schatz C, Touhami S, Touitou V, Vignal C, Zech C. [Categorization of the degree of urgency according to ophthalmology procedures or situations]. J Fr Ophtalmol. 2020 Jun;43(6):525–8.
  • Vandefonteyne S, Caujolle J-P, Rosier L, Conrath J, Quentel G, Tadayoni R, Maschi C, Le Mer Y, Dot C, Aknin I, Thariat J, Baillif S. Diagnosis and treatment of peripheral exudative haemorrhagic chorioretinopathy. Br J Ophthalmol. 2020 Jun;104(6):874–8.
  • Signetti L, Elizarov N, Simsir M, Paquet A, Douguet D, Labbal F, Debayle D, Di Giorgio A, Biou V, Girard C, Duca M, Bretillon L, Bertolotto C, Verrier B, Azoulay S, Mus-Veteau I. Inhibition of Patched Drug Efflux Increases Vemurafenib Effectiveness against Resistant BrafV600E Melanoma. Cancers (Basel). 2020 Jun 9;12(6).
  • Martel A, Farah E, Zmuda M, Almairac F, Jacomet PV, Galatoire O. Autologous dermis graft versus conchal cartilage graft for managing lower eyelid retraction: A comparative study. Eur J Ophthalmol. 2020 Jun 12;1120672120934408.
  • Hofman V, Benzaquen J, Heeke S, Lassalle S, Poudenx M, Long E, Lantéri E, Bordone O, Lespinet V, Tanga V, Bonnetaud C, Bille Y, Ilié M, Marquette C, Barlesi F, Boutros J, Hofman P. Real-world assessment of the BRAF status in non-squamous cell lung carcinoma using VE1 immunohistochemistry: A single laboratory experience (LPCE, Nice, France). Lung Cancer. 2020 Jul;145:58–62.
  • Martel A, Caujolle JP, Baillif S, Maschi C, Lassalle S, Nahon-Esteve S. Mascara deposits in an anophthalmic socket mimicking a conjunctival melanoma. J Fr Ophtalmol. 2020 Aug 15;
  • Fajnkuchen F, Delyfer M-N, Conrath J, Baillif S, Mrejen S, Srour M, Bellamy J-P, Dupas B, Lecleire-Collet A, Meillon C, Bonicel P, Hobeika M, Giocanti-Aurégan A. Expectations and fears of patients with diabetes and macular edema treated by intravitreal injections. Acta Diabetol. 2020 Sep;57(9):1081–91.
  • Jain P, Finger PT, Fili M, Damato B, Coupland SE, Heimann H, Kenawy N, J Brouwer N, Marinkovic M, Van Duinen SG, Caujolle JP, Maschi C, Seregard S, Pelayes D, Folgar M, Yousef YA, Krema H, Gallie B, Calle-Vasquez A, American Joint Committee on Cancer Ophthalmic Oncology Task Force. Conjunctival melanoma treatment outcomes in 288 patients: a multicentre international data-sharing study. Br J Ophthalmol. 2020 Sep 5;
  • Nahon-Estève S, Martel A, Maschi C, Baillif S, Lassalle S, Caujolle J-P. Swept-Source and Spectral-Domain OCT Imaging of Conjunctival Tumors. Ophthalmology. 2020 Sep 29;
  • Nahon-Esteve S, Martel A, Maschi C, Alketbi M, Baillif S, Tieulie N. Uveitis associated with latent tuberculosis: A comparative study of the impact of antitubercular therapy combined or not with systemic corticosteroids. Eur J Ophthalmol. 2020 Oct 2;1120672120962066.
  • Martel A, Baillif S, Thomas P, Almairac F, Galatoire O, Hamedani M, Fontaine D, Lanteri-Minet M. Phantom eye pain: a multicentric study in 100 patients. Acta Ophthalmol. 2020 Oct 29;
  • Gaudel C, Soysouvanh F, Leclerc J, Bille K, Husser C, Montcriol F, Bertolotto C, Ballotti R. Regulation of Melanogenesis by the Amino Acid Transporter SLC7A5. J Invest Dermatol. 2020 Nov;140(11):2253-2259.e4.
  • Martel A, Baillif S, Nahon-Esteve S, Gastaud L, Bertolotto C, Roméo B, Mograbi B, Lassalle S, Hofman P. Liquid Biopsy for Solid Ophthalmic Malignancies: An Updated Review and Perspectives. Cancers (Basel). 2020 Nov 6;12(11).
  • Fish A-L, Alketbi M, Baillif S. Evaluation of a New Test for the Diagnosis of Congenital Dyschromatopsia in Children: the Color Vision Evaluation Test. Am J Ophthalmol. 2020 Nov 19;223:348–58.
  • Lassalle S, Nahon-Esteve S, Frouin E, Boulagnon-Rombi C, Josselin N, Cassoux N, Barnhill R, Scheller B, Baillif S, Hofman P. PD-L1 Expression in 65 Conjunctival Melanomas and Its Association with Clinical Outcome. Int J Mol Sci. 2020 Nov 30;21(23).
  • Barrière S, Gastaud L. [European approvals: Glasdegib for Acute myeloid leukemia]. Bull Cancer. 2020 Dec;107(12):1206–7.
  • Carle X, Gastaud L, Salleron J, Tardy MP, Caujolle J-P, Thyss A, Thariat J, Chevallier P. Optimizing the treatment of liver metastases from uveal melanomas with transarterial chemoembolization using melphalan and calibrated microspheres. Bull Cancer. 2020 Dec;107(12):1274–83.
  • Tanga V, Leroy S, Fayada J, Hamila M, Allegra M, Messaoudi Z, Bonnetaud C, Lespinet V, Bordone O, Washetine K, Griffonnet J, Maniel C, Philibert L, Selva E, Benzaquen J, Ilie M, Long E, Lassalle S, Lantéri E, Marquette C-H, Hofman V, Hofman P. Establishment of a Collection of Blood-Derived Products from COVID-19 Patients for Translational Research: Experience of the LPCE Biobank (Nice, France). Biopreserv Biobank. 2020 Dec;18(6):517–24.
  • Martel A, Nahon-Estève S, Appert Flory A, Lassalle S, Leonardo S, Tieulié N, Caujolle J-P. Ligneous conjunctivitis masquerading as a large, recurrent conjunctival tumor. J Fr Ophtalmol. 2020 Dec 4;
  • Ballotti R, Cheli Y, Bertolotto C. The complex relationship between MITF and the immune system: a Melanoma ImmunoTherapy (response) Factor? Mol Cancer. 2020 Dec 5;19(1):170.

2019

  • Casadei-Gardini A, Montagnani F, Casadei C, Arcadipane F, Andrikou K, Aloi D, Prete AA, Zampino MG, Argentiero A, Pugliese G, Martini S, Iorio GC, Scartozzi M, Mistrangelo M, Fornaro L, Cassoni P, Marisi G, Dell’Acqua V, Ravenda PS, Lonardi S, Silvestris N, De Bari B, Ricardi U, Cascinu S, Franco P. Immune inflammation indicators in anal cancer patients treated with concurrent chemoradiation: training and validation cohort with online calculator (ARC: Anal Cancer Response Classifier). Cancer Manag Res. 2019;11:3631–42.
  • Malissen N, Macagno N, Granjeaud S, Granier C, Moutardier V, Gaudy-Marqueste C, Habel N, Mandavit M, Guillot B, Pasero C, Tartour E, Ballotti R, Grob J-J, Olive D. HVEM has a broader expression than PD-L1 and constitutes a negative prognostic marker and potential treatment target for melanoma. Oncoimmunology. 2019;8(12):e1665976.
  • Nahon-Esteve S, Martel A, Maschi C, Caujolle J-P, Baillif S, Lassalle S, Hofman P. The Molecular Pathology of Eye Tumors: A 2019 Update Main Interests for Routine Clinical Practice. Curr Mol Med. 2019;19(9):632–64.
  • Berland L, Heeke S, Humbert O, Macocco A, Long-Mira E, Lassalle S, Lespinet-Fabre V, Lalvée S, Bordone O, Cohen C, Leroy S, Hofman V, Hofman P, Ilié M. Current views on tumor mutational burden in patients with non-small cell lung cancer treated by immune checkpoint inhibitors. J Thorac Dis. 2019 Jan;11(Suppl 1):S71–80.
  • Mathis T, Jardel P, Loria O, Delaunay B, Nguyen A-M, Lanza F, Mosci C, Caujolle J-P, Kodjikian L, Thariat J. New concepts in the diagnosis and management of choroidal metastases. Prog Retin Eye Res. 2019 Jan;68:144–76.
  • Garandeau D, Noujarède J, Leclerc J, Imbert C, Garcia V, Bats M-L, Rambow F, Gilhodes J, Filleron T, Meyer N, Brayer S, Arcucci S, Tartare-Deckert S, Ségui B, Marine J-C, Levade T, Bertolotto C, Andrieu-Abadie N. Targeting the Sphingosine 1-Phosphate Axis Exerts Potent Antitumor Activity in BRAFi-Resistant Melanomas. Mol Cancer Ther. 2019 Feb;18(2):289–300.
  • Leclerc J, Garandeau D, Pandiani C, Gaudel C, Bille K, Nottet N, Garcia V, Colosetti P, Pagnotta S, Bahadoran P, Tondeur G, Mograbi B, Dalle S, Caramel J, Levade T, Ballotti R, Andrieu-Abadie N, Bertolotto C. Lysosomal acid ceramidase ASAH1 controls the transition between invasive and proliferative phenotype in melanoma cells. Oncogene. 2019 Feb;38(8):1282–95.
  • Wiedemann GM, Aithal C, Kraechan A, Heise C, Cadilha BL, Zhang J, Duewell P, Ballotti R, Endres S, Bertolotto C, Kobold S. Microphthalmia-Associated Transcription Factor (MITF) Regulates Immune Cell Migration into Melanoma. Transl Oncol. 2019 Feb;12(2):350–60.
  • Boulahssass R, Gonfrier S, Champigny N, Lassalle S, François E, Hofman P, Guerin O. The Desire to Better Understand Older Adults with Solid Tumors to Improve Management: Assessment and Guided Interventions-The French PACA EST Cohort Experience. Cancers (Basel). 2019 Feb 7;11(2).
  • Hofman P, Badoual C, Henderson F, Berland L, Hamila M, Long-Mira E, Lassalle S, Roussel H, Hofman V, Tartour E, Ilié M. Multiplexed Immunohistochemistry for Molecular and Immune Profiling in Lung Cancer-Just About Ready for Prime-Time? Cancers (Basel). 2019 Feb 27;11(3).
  • Heeke S, Delingette H, Fanjat Y, Long-Mira E, Lassalle S, Hofman V, Benzaquen J, Marquette C-H, Hofman P, Ilié M. [The age of artificial intelligence in lung cancer pathology: Between hope, gloom and perspectives]. Ann Pathol. 2019 Apr;39(2):130–6.
  • Martel A, Caujolle JP, Alketbi M, Rives P, Poissonnet G. [Use of an artifical dermal template for the reconstruction of the exenterated sockets]. J Fr Ophtalmol. 2019 Apr;42(4):e169–71.
  • Santoni A, Thariat J, Maschi C, Herault J, Baillif S, Lassalle S, Peyrichon ML, Salleron J, Caujolle J-P. Management of Invasive Squamous Cell Carcinomas of the Conjunctiva. Am J Ophthalmol. 2019 Apr;200:1–9.
  • Martel A, Oberic A, Moulin A, Zografos L, Hamedani M. Eyelids metastases from uveal melanoma: clinical and histopathologic features of two cases and literature review. Eye (Lond). 2019 May;33(5):767–71.
  • Mathis T, Rosier L, Meniai F, Baillif S, Maschi C, Herault J, Caujolle J-P, Kodjikian L, Salleron J, Thariat J. The Lens Opacities Classification System III Grading in Irradiated Uveal Melanomas to Characterize Proton Therapy-Induced Cataracts. Am J Ophthalmol. 2019 May;201:63–71.
  • Tulic MK, Cavazza E, Cheli Y, Jacquel A, Luci C, Cardot-Leccia N, Hadhiri-Bzioueche H, Abbe P, Gesson M, Sormani L, Regazzetti C, Beranger GE, Lereverend C, Pons C, Khemis A, Ballotti R, Bertolotto C, Rocchi S, Passeron T. Innate lymphocyte-induced CXCR3B-mediated melanocyte apoptosis is a potential initiator of T-cell autoreactivity in vitiligo. Nat Commun. 2019 May 16;10(1):2178.
  • Jouhi S, Jager MJ, de Geus SJR, Desjardins L, Eide NA, Grange J-D, Kiilgaard JF, Seregard S, Midena E, Parrozzani R, Caujolle J-P, Rospond-Kubiak I, Kivelä TT. The Small Fatal Choroidal Melanoma Study. A Survey by the European Ophthalmic Oncology Group. Am J Ophthalmol. 2019 Jun;202:100–8.
  • Jain P, Finger PT, Damato B, Coupland SE, Heimann H, Kenawy N, Brouwer NJ, Marinkovic M, Van Duinen SG, Caujolle JP, Maschi C, Seregard S, Pelayes D, Folgar M, Yousef YA, Krema H, Gallie B, Calle-Vasquez A, American Joint Committee on Cancer Ophthalmic Oncology Task Force. Multicenter, International Assessment of the Eighth Edition of the American Joint Committee on Cancer Cancer Staging Manual for Conjunctival Melanoma. JAMA Ophthalmol. 2019 Jun 6;
  • Ballotti R, Healy E, Bertolotto C. Nicotinamide as a chemopreventive therapy of skin cancers. Too much of good thing? Pigment Cell Melanoma Res. 2019 Jul;32(4):601–2.
  • Hofman V, Rouquette I, Long-Mira E, Piton N, Chamorey E, Heeke S, Vignaud JM, Yguel C, Mazières J, Lepage A-L, Bibeau F, Begueret H, Lassalle S, Lalvée S, Zahaf K, Benzaquen J, Poudenx M, Marquette C-H, Sabourin J-C, Ilié M, Hofman P. Multicenter Evaluation of a Novel ROS1 Immunohistochemistry Assay (SP384) for Detection of ROS1 Rearrangements in a Large Cohort of Lung Adenocarcinoma Patients. J Thorac Oncol. 2019 Jul;14(7):1204–12.
  • Kenawy N, Kalirai H, Sacco JJ, Lake SL, Heegaard S, Larsen A-C, Finger PT, Milman T, Chin K, Mosci C, Lanza F, Moulin A, Schmitt CA, Caujolle JP, Maschi C, Marinkovic M, Taktak AF, Heimann H, Damato BE, Coupland SE. Conjunctival melanoma copy number alterations and correlation with mutation status, tumor features, and clinical outcome. Pigment Cell Melanoma Res. 2019 Jul;32(4):564–75.
  • Hofman P, Benzaquen J, Lassalle S, Diascorn Y, Cohen C. [Pseudo-tumor lesions induced by infectious agents. Case no. 8]. Ann Pathol. 2019 Aug;39(4):277–9.
  • Martel A, Bougaci N, Lagier J, Almairac F, Dagain A. Post-traumatic orbitorrhea: An underestimated life-threatening complication following anterior skull base fractures. Eur J Ophthalmol. 2019 Aug 2;1120672119867827.
  • Perol L, Grignano E, Contejean A, Gastaud L, Legoff M, Franchi P, Deau-Fischer B, Willems L, Bouscary D, Tamburini J. High-dose chemotherapy without transfusion for Philadelphia chromosome negative B-cell acute lymphoblastic leukemia in two Jehovah’s Witnesses patients: a feasible option in the age of hematopoietic growth factors. Leuk Lymphoma. 2019 Sep;60(9):2324–7.
  • Martel A, Lassalle S, Gastaud L, Maschi C, Caujolle JP, Nahon-Esteve S. [Local, regional and systemic dissemination of choroidal melanoma : Clinical and pathological correlation from 2 cases]. J Fr Ophtalmol. 2019 Oct;42(8):834–8.
  • Botton T, Talevich E, Mishra VK, Zhang T, Shain AH, Berquet C, Gagnon A, Judson RL, Ballotti R, Ribas A, Herlyn M, Rocchi S, Brown KM, Hayward NK, Yeh I, Bastian BC. Genetic Heterogeneity of BRAF Fusion Kinases in Melanoma Affects Drug Responses. Cell Rep. 2019 Oct 15;29(3):573-588.e7.
  • Thariat J, Salleron J, Maschi C, Fevrier E, Lassalle S, Gastaud L, Baillif S, Claren A, Baumard F, Herault J, Caujolle JP. Oncologic and visual outcomes after postoperative proton therapy of localized conjunctival melanomas. Radiat Oncol. 2019 Dec 27;14(1):239.

Dernière révision : 01/01/2021

Faire un don

Soutenez-nous dans nos combats contre les cancers oculaires !

Le Département d’Onco-Ophtalmologie Niçois (DOON) dispose d’un Fonds de dotation destiné à recevoir des dons. Les fonds sont utilisés pour le financement de projets scientifiques et médicaux de recherche, des projets d’éducation thérapeutique pour les patients ou des projets visant à améliorer de la qualité de vie des patients présentant une tumeur oculaire.

Nous utilisons des cookies pour vous offrir la meilleure expérience possible. Vous pouvez en savoir plus sur les cookies que nous utilisons ou les désactiver dans les paramètres de confidentialité.
AccepterParamètres de confidentialité

Paramétrages

  • Gestion des cookies
  • Youtube

Gestion des cookies

Ce site web utilise des traceurs visant à générer des statistiques de fréquentation lors de votre navigation sur le site. Aucune donnée n’est partagé auprès de tiers. En savoir plus sur la politique de confidentialité du DOON.

You may choose to prevent this website from aggregating and analyzing the actions you take here. Doing so will protect your privacy, but will also prevent the owner from learning from your actions and creating a better experience for you and other users.

Youtube

Pour afficher vidéo youtube